Shana D. Hardy

585 total citations
7 papers, 456 citations indexed

About

Shana D. Hardy is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Shana D. Hardy has authored 7 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Shana D. Hardy's work include Cancer-related gene regulation (3 papers), Cancer Cells and Metastasis (3 papers) and Autophagy in Disease and Therapy (2 papers). Shana D. Hardy is often cited by papers focused on Cancer-related gene regulation (3 papers), Cancer Cells and Metastasis (3 papers) and Autophagy in Disease and Therapy (2 papers). Shana D. Hardy collaborates with scholars based in United States, India and Australia. Shana D. Hardy's co-authors include Robert L. Geahlen, Wen‐Horng Wang, Arvind Raman, Yuri M. Efremov, Aparna Shinde, Michael K. Wendt, Honghe Wang, Timothy Turner, Jacqueline Jones and William E. Grizzle and has published in prestigious journals such as Cancer Research, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Shana D. Hardy

7 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shana D. Hardy United States 5 205 131 117 75 71 7 456
Mircea Leabu Romania 11 158 0.8× 99 0.8× 29 0.2× 154 2.1× 48 0.7× 22 503
Koichi Doi Japan 9 262 1.3× 97 0.7× 36 0.3× 53 0.7× 26 0.4× 52 643
Doogie Oh United States 6 247 1.2× 106 0.8× 36 0.3× 44 0.6× 41 0.6× 11 444
Yuichi Tanaka Japan 9 191 0.9× 29 0.2× 63 0.5× 46 0.6× 40 0.6× 45 450
Nicolas Schierbaum Germany 7 86 0.4× 246 1.9× 153 1.3× 64 0.9× 161 2.3× 10 450
Fei Xiao China 15 176 0.9× 36 0.3× 24 0.2× 58 0.8× 88 1.2× 58 513
Lily H. Laiho United States 6 121 0.6× 105 0.8× 38 0.3× 47 0.6× 211 3.0× 11 577
Karissa Tilbury United States 13 116 0.6× 77 0.6× 20 0.2× 44 0.6× 166 2.3× 18 473
Maia Vinogradova United States 10 374 1.8× 90 0.7× 65 0.6× 77 1.0× 15 0.2× 15 645
Joshua A. Mason United States 6 156 0.8× 36 0.3× 18 0.2× 41 0.5× 56 0.8× 15 322

Countries citing papers authored by Shana D. Hardy

Since Specialization
Citations

This map shows the geographic impact of Shana D. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shana D. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shana D. Hardy more than expected).

Fields of papers citing papers by Shana D. Hardy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shana D. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shana D. Hardy. The network helps show where Shana D. Hardy may publish in the future.

Co-authorship network of co-authors of Shana D. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Shana D. Hardy. A scholar is included among the top collaborators of Shana D. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shana D. Hardy. Shana D. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Shinde, Aparna, Shana D. Hardy, Dong Wook Kim, et al.. (2019). Spleen Tyrosine Kinase–Mediated Autophagy Is Required for Epithelial–Mesenchymal Plasticity and Metastasis in Breast Cancer. Cancer Research. 79(8). 1831–1843. 97 indexed citations
2.
Shinde, Aparna, Shana D. Hardy, Dong Wook Kim, et al.. (2019). Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer. NOT FOUND REPOSITORY (Indian Institute of Science Bangalore). 1 indexed citations
3.
Efremov, Yuri M., Wen‐Horng Wang, Shana D. Hardy, Robert L. Geahlen, & Arvind Raman. (2017). Measuring nanoscale viscoelastic parameters of cells directly from AFM force-displacement curves. Scientific Reports. 7(1). 1541–1541. 195 indexed citations
4.
Hardy, Shana D., Aparna Shinde, Wen‐Horng Wang, Michael K. Wendt, & Robert L. Geahlen. (2017). Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy. Oncotarget. 8(61). 103302–103314. 72 indexed citations
5.
Hardy, Shana D. & Robert L. Geahlen. (2015). Abstract 4972: Investigating the role of Syk in TGF-β induced P-bodies and breast cancer metastasis. Cancer Research. 75(15_Supplement). 4972–4972. 1 indexed citations
6.
Wang, Honghe, Jacqueline Jones, Timothy Turner, et al.. (2012). Clinical and Biological Significance of KISS1 Expression in Prostate Cancer. American Journal Of Pathology. 180(3). 1170–1178. 38 indexed citations
7.
Jones, Jacqueline, Honghe Wang, Shana D. Hardy, et al.. (2012). Nuclear Kaiso Indicates Aggressive Prostate Cancers and Promotes Migration and Invasiveness of Prostate Cancer Cells. American Journal Of Pathology. 181(5). 1836–1846. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026